Literature DB >> 21266333

Indications of possible brain-tumour risk in mobile-phone studies: should we be concerned?

Elisabeth Cardis, Siegal Sadetzki.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21266333     DOI： 10.1136/oem.2010.061358

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN： 1351-0711            Impact factor:   4.402


× No keyword cloud information.
  5 in total

1.  The Intracranial Distribution of Gliomas in Relation to Exposure From Mobile Phones: Analyses From the INTERPHONE Study.

Authors:  Kathrine Grell; Kirsten Frederiksen; Joachim Schüz; Elisabeth Cardis; Bruce Armstrong; Jack Siemiatycki; Daniel R Krewski; Mary L McBride; Christoffer Johansen; Anssi Auvinen; Martine Hours; Maria Blettner; Siegal Sadetzki; Susanna Lagorio; Naohito Yamaguchi; Alistair Woodward; Tore Tynes; Maria Feychting; Sarah J Fleming; Anthony J Swerdlow; Per K Andersen
Journal:  Am J Epidemiol       Date:  2016-11-03       Impact factor: 4.897

2.  Mobile phones and head tumours. The discrepancies in cause-effect relationships in the epidemiological studies - how do they arise?

Authors:  Angelo G Levis; Nadia Minicuci; Paolo Ricci; Valerio Gennaro; Spiridione Garbisa
Journal:  Environ Health       Date:  2011-06-17       Impact factor: 5.984

3.  Metabolomics and psychological features in fibromyalgia and electromagnetic sensitivity.

Authors:  Cristina Piras; Stella Conte; Monica Pibiri; Giacomo Rao; Sandro Muntoni; Vera Piera Leoni; Gabriele Finco; Luigi Atzori
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

4.  New Zealand adolescents' cellphone and cordless phone user-habits: are they at increased risk of brain tumours already? A cross-sectional study.

Authors:  Mary Redmayne
Journal:  Environ Health       Date:  2013-01-10       Impact factor: 5.984

5.  Case-control study of the association between malignant brain tumours diagnosed between 2007 and 2009 and mobile and cordless phone use.

Authors:  Lennart Hardell; Michael Carlberg; Fredrik Söderqvist; Kjell Hansson Mild
Journal:  Int J Oncol       Date:  2013-09-24       Impact factor: 5.650
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.